EpiVax is currently engaged in multiple collaborations focused on our Tregitope technology. For more information on any of the following collaborations please contact Anthony Marcello – .

Collaborator Affiliation Target
David Scott, Ph.D. Uniformed Services University of the Health Services Diabetes, FVIII
Achsah Keegan, Ph.D. University of Maryland Allergy
Mo Sayegh, M.D. Brigham and Women’s, Harvard University Transplantation
Nader Najafian, M.D. Brigham and Women’s, Harvard University Transplantation
Andrew Issekutz, M.D.. Dalhousie University IgG
Benoit Salomon CERV Uveitis
Ziad Mallat, M.D., Ph.D. INSERM Atherosclerosis
Katherine High, M.D. Children’s Hospital of Philadelphia Gene Therapy
Samia Khoury, M.D. Brigham and Women’s, Harvard University MS/EAE
Leslie De Groot, M.D. University of Rhode Island TSHR

Previous Non-Confidential Clients

DeFT and/or PreDeFT Vaccine Design
Astrazeneca Acambis
Biosynexus Harvard University
BioMarin Dana Farber Cancer Institute
Eli Lilly Brown University
Maxygen University of Pennsylvania
MedImmune University of Massachusetts
Regeneron Miriam Hospital
Spinal Therapies MedImmune
Trophogen Rhode Island Hospital
University of Rhode Island
University of Rochester
Saint Louis University
Vanderbilt University
Tufts University